title: [What's new in 2008 in the field of basic and clinical research in testicular and penile cancer?].
abstract: Few communications were devoted this year to the cancers of the male external genital organs. In stage I testis seminomas, data comparing 1 course of chemotherapy by carboplatin (AUC: 7) to retroperitoneal radiotherapy in adjuvant treatment were updated. Localizations of recurrences were different, depending on adjuvant treatment. In stage I non seminomatous testis cancer, active surveillance could be possible if there were not any vascular embols. Chemotherapy by 1 course of BEP was superior to retroperitoneal lymph node dissection in stage I. In Leydig cell tumors, conservative surgery was possible. In penile cancer management, dynamic sentinel node biopsy could be interesting. Carbon-dioxide laser microsurgery only for initially invasive squamous cell carcinoma of the penis could be proposed.
authors.affiliation: Service d'Urologie Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalo-universitaire Est, Faculté de médecine Pierre et Marie Curie, Université Paris VI, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Phé
authors.forename: M
authors.initials: M
authors.lastname: Rouprêt
authors.forename: N
authors.initials: N
authors.lastname: Mottet
mesh_terms: D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D010412:Penile Neoplasms / Q000628:therapy*; D013736:Testicular Neoplasms / Q000628:therapy*